Cardio Diagnostics Statistics
Share Statistics
Cardio Diagnostics has 40.44M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 40.44M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 300 |
FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.68M, so 4.15% of the outstanding shares have been sold short.
Short Interest | 1.68M |
Short % of Shares Out | 4.15% |
Short % of Float | 4.9% |
Short Ratio (days to cover) | 0.7 |
Valuation Ratios
The PE ratio is -3.77 and the forward PE ratio is -1.44.
PE Ratio | -3.77 |
Forward PE | -1.44 |
PS Ratio | 1850.92 |
Forward PS | 97.4 |
PB Ratio | 10.68 |
P/FCF Ratio | -4.9 |
PEG Ratio | n/a |
Enterprise Valuation
Cardio Diagnostics Inc. has an Enterprise Value (EV) of 31.56M.
EV / Earnings | -3.77 |
EV / Sales | 1849.6 |
EV / EBITDA | -20.63 |
EV / EBIT | -4.36 |
EV / FCF | -4.9 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.13.
Current Ratio | 3.29 |
Quick Ratio | 3.29 |
Debt / Equity | 0.13 |
Total Debt / Capitalization | 11.22 |
Cash Flow / Debt | -15.17 |
Interest Coverage | -1.08 |
Financial Efficiency
Return on equity (ROE) is -2.83% and return on capital (ROIC) is -171.66%.
Return on Equity (ROE) | -2.83% |
Return on Assets (ROA) | -1.88% |
Return on Capital (ROIC) | -171.66% |
Revenue Per Employee | 2.44K |
Profits Per Employee | -1.20M |
Employee Count | 7 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -46.15% in the last 52 weeks. The beta is 4.68, so Cardio Diagnostics 's price volatility has been higher than the market average.
Beta | 4.68 |
52-Week Price Change | -46.15% |
50-Day Moving Average | 0.35 |
200-Day Moving Average | 0.61 |
Relative Strength Index (RSI) | 73.89 |
Average Volume (20 Days) | 6.07M |
Income Statement
In the last 12 months, Cardio Diagnostics had revenue of $17.07K and earned -$8.38M in profits. Earnings per share was $-0.66.
Revenue | 17.07K |
Gross Profit | 17.07K |
Operating Income | -7.24M |
Net Income | -8.38M |
EBITDA | -1.53M |
EBIT | -7.24M |
Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has $1.28M in cash and $1.26M in debt, giving a net cash position of $22.50K.
Cash & Cash Equivalents | 1.28M |
Total Debt | 1.26M |
Net Cash | 22.50K |
Retained Earnings | -14.37M |
Total Assets | 4.48M |
Working Capital | 2.32M |
Cash Flow
In the last 12 months, operating cash flow was -$5.67M and capital expenditures -$772.94K, giving a free cash flow of -$6.45M.
Operating Cash Flow | -5.67M |
Capital Expenditures | -772.94K |
Free Cash Flow | -6.45M |
FCF Per Share | -0.51 |
Margins
Gross margin is 100%, with operating and profit margins of -42.44K% and -49.09K%.
Gross Margin | 100% |
Operating Margin | -42.44K% |
Pretax Margin | -49.09K% |
Profit Margin | -49.09K% |
EBITDA Margin | -8.97K% |
EBIT Margin | -42.44K% |
FCF Margin | -37.77K% |
Dividends & Yields
CDIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -52.38% |
FCF Yield | -12.6% |
Analyst Forecast
Currently there are no analyst rating for CDIO.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 24.61 |
Piotroski F-Score | 5 |